HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


L’Oreal Settles With FTC Over Gene-Related Anti-Aging Skin-Care Claims

This article was originally published in The Rose Sheet

Executive Summary

A proposed consent agreement between L’Oreal USA and the Federal Trade Commission bars the company from claiming that skin-care products from its Lancome and L’Oreal Paris brands target users’ genes to award anti-aging benefits. The settlement, which is subject to public comment and final FTC approval, follows a 2012 warning letter from FDA that cited some of the same marketing claims.


Related Content

Adore Settles With Nationwide Class Over Apple Stem Cell Anti-Aging Claims
Class Action Blight: The Sour Side Of Apple Stem Cell Anti-Aging Boom
Aggressive Claims, FDA Warnings Make Beauty A Bull’s Eye For Litigation
FDA Warns Lancome For Gene/Stem-Cell Claims: A Signal To Marketplace?

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts